Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: The University of Texas Health Science Center, Houston
Condition: Pancreatic Ductal Adenocarcinoma
NCT06831136
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.